Government Briefs

Requests to fund university research facilities, also known as "academic pork," that have become a growing and controversial part of the congressional budget-making process have been trimmed in the 1989 appropriations for the Department of Energy. Only two such projects, totaling $16.6 million, appear in the bill passed May 17 by the House, in contrast to nine projects, worth $73.7 million, that the House approved last year. Loma Linda University’s Proton Beam Cancer Treatment Center ($1

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Requests to fund university research facilities, also known as "academic pork," that have become a growing and controversial part of the congressional budget-making process have been trimmed in the 1989 appropriations for the Department of Energy. Only two such projects, totaling $16.6 million, appear in the bill passed May 17 by the House, in contrast to nine projects, worth $73.7 million, that the House approved last year. Loma Linda University’s Proton Beam Cancer Treatment Center ($11.1 million) and Drexel University’s Center for Automated Technologies ($5.5 million) are the lone survivors from last year’s litter, and no new projects are contained in the spending measure, the first of 13 appropriations bills scheduled to come before the House. Beyond simple belt-tightening, the upcoming change in the White House left lawmakers unwilling to go to bat for projects that could be cut next year.

here in the bill, the House provides only $100 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies